-
Forward Look
A Report Card on Active SurveillanceMany men with untreated prostate cancer are not getting proper follow-up.
by Heather Stringer
-
Forward Look
Fine-Tuning Treatments for Triple-Negative Breast CancerStudies aim to identify best available treatments and find new ones.
by Cameron Walker
-
Healthy Habits
Less StressCognitive-behavioral stress management may help women with breast cancer.
by Brenda Conaway
-
Forward Look
Aspirin Recommended to Reduce Colorectal Cancer RiskTask force formally recognizes the benefits, with caveats.
by Yasmine Iqbal
-
Survivor Profile
Living in the Here and NowA metastatic melanoma survivor is hopeful but realistic as new treatments become available.
by Jenny Song
-
Forward Look
Melanoma Risk Increased in Some Lymphoma SurvivorsStudy pinpoints group that may benefit from close surveillance.
by Sharon Reynolds
-
Forward Look
Uterine Cancer Rates on the RiseStudy finds deaths are highest among African-American women.
by Brenda Conaway
-
Forward Look
Cancer Immunotherapies Continue to Make HeadwayDrugs that harness the power of the immune system gain new approvals.
by Alexandra Goho
-
From the Editor-in-Chief
Early-Stage Prostate Cancer: To Treat or Not To TreatStrategies for prostate cancer screening and surveillance are still being refined.
by William G. Nelson, MD, PhD
-
Yesterday & Today
A Storied LifeLiterary realist John Updike used the scaffold of his own life, including his lung cancer diagnosis, to explore the shared experiences of our time.
by Sue Rochman
Cancer Talk
Injection Immunotherapies Get FDA Approval
Giving immunotherapy drugs as injections, rather than intravenously, means patients can spend less time in the hospital or treatment center.
by Laura Gesualdi-Gilmore
Designing Clinical Trials for the PatientChallenges in developing and studying treatments call for new ways of thinking about cancer research.
by Eric Fitzsimmons
Treating Smoldering Multiple MyelomaA monoclonal antibody drug reduced the risk of smoldering myeloma progressing to multiple myeloma in patients at high risk for disease progression.
by Sandra Gordon
Immunotherapy Improves Survival in Bladder CancerNew research indicates that adding immunotherapy to muscle-invasive bladder cancer treatment can improve event-free and overall survival.
by Laura Gesualdi-Gilmore